Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Solid-state battery technology company Ilika said it had developed processing methods to enable 'rapid customisation' of its Stereax thin film cells to match customers' requirements.
The announcements comes after the company on 10 April launched its Stereax M50 mm-scale solid state batteries for MedTech using photolithography, marking a move away from the use of contact masks, which were deployed to produce earlier Stereax products.
Compared to materials used in other contract masks, the use of photolithography had the 'advantage' of being able to create smaller feature sizes, of less than a micron, the company said. This also cut the lead time for creating new wafer layouts by up to 85%, and 'significantly' lowered operating costs.
'The replacement of contact masks with a photolithographic method is an important step in being able to offer customised solutions to high value proprietary applications for Stereax products, said Ilika's CEO Graeme Purdy.
At 9:30am: (LON:IKA) Ilika share price was +0.5p at 30.5p